News Feature

The Stanford-led research tested an approach that allowed women to choose the level of pain management they wanted during a cesarean section.

Canagliflozin, a drug approved to lower glucose levels in diabetic patients, can slow the progression of kidney disease, according to a study co-authored by a Stanford Medicine researcher.

In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.

Through a combination of biometric tracking, simulated modeling and medical imaging, Stanford researchers have detailed how hits to the side of the head may cause concussion.

On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the thinking in his field about what causes a common and often lethal heart defect.

Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.

On March 15, Stanford medical students nervously awaited the moment they could find out where they had matched for their residencies.

With no blood flow to his right lung, infant Carter Johnson was diagnosed with a rare condition called absent right pulmonary artery. His parents turned to Stanford Children’s Health for help.

Patients who took statins less than 70 percent of the time had a 20 percent increase in mortality compared with those taking them at least 90 percent of the time, a Stanford study found.

A nurse-scientist at Lucile Packard Children’s Hospital Stanford has discovered a passion for science, and advocates for bringing the nursing perspective into clinical research.